Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from ...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look ...

Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 ...

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look ...

In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.

Request To Download Free Sample of This Strategic Report @ Highlighted with 38 tables and 62 figures, this 127-page report ?Europe Endoscopy Devices Market 2023-2033 by Device Type, Hygiene, ...

Innovation has “created a tailwind for the company that that we haven’t had in a long time,” Medtronic CEO Geoff Martha said at the 2025 J.P. Morgan Healthcare Conference. “These are growth-drivers ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes ...

Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

Medtronic’s Percept PC neurostimulator with BrainSense technology [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that it received CE mark approval for its BrainSense ...

(RTTNews) - Medtronic plc (MDT), Monday said it received CE Mark approval for its BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier in the European Union and ...